21 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
in place to safeguard personal data and requires us to adopt appropriate privacy governance including policies, procedures, training and data audit. We
ARS
yl7 jnjzjm0w
28 Apr 23
Annual report to shareholders
7:03am
PRE 14A
5sj8lruo0wt0d wkhcrw
18 Apr 23
Preliminary proxy
7:59am
DEF 14A
peqy6vbi
26 Apr 21
Definitive proxy
4:22pm
424B4
g58r511l4fs3e4v
2 Oct 20
Prospectus supplement with pricing info
5:10pm
S-1/A
cp95hwynz 4gflqgttn
28 Sep 20
IPO registration (amended)
6:07am
S-1
5gacr5 99q8ypc7
10 Sep 20
IPO registration
5:26pm
S-1
EX-10.9
t3s0byzg6
10 Sep 20
IPO registration
5:26pm
S-1
EX-10.11
ps4xbtry5pk upa3kof
10 Sep 20
IPO registration
5:26pm
S-1
EX-10.13
0rutz4lgzy57fdipj kf
10 Sep 20
IPO registration
5:26pm
DRS
EX-10.8
xt536z
6 Aug 20
Draft registration statement
12:00am
DRS
jgjvezdp
6 Aug 20
Draft registration statement
12:00am